ARTICLE | Clinical News
Genasense injection oblimersen sodium: Phase III ongoing
May 25, 2009 7:00 AM UTC
Genta said an independent data monitoring board recommended continuation of the double-blind, placebo-controlled, international Phase III AGENDA trial based on planned analyses for safety and futility...